Zoi Kontogeorgiou

Zoi Kontogeorgiou

Auto-generated profile, based on publicly available information

Zoi Kontogeorgiou

Neurogenetics Unit, 1st Department of Neurology, Eginition Hospital, School of Medicine National and Kapodistrian University of Athens Athens Greece

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 March 2021 in Clinical Genetics
Verified
Journal Article
Closed access
PDF file
ZKZoi Kontogeorgiou
Zoi Kontogeorgiou
CKChrisoula Kartanou
Chrisoula Kartanou
CTChrysanthi Tsirligkani
Chrysanthi Tsirligkani
EAEvangelos Anagnostou
Evangelos Anagnostou
MRMichail Rentzos
Michail Rentzos
GKGeorgios Koutsis
Georgios Koutsis

1 January 2017 in Nitric Oxide
Verified
Journal Article
Closed access
IAIakovos Armenis
Iakovos Armenis
VKVassiliki Kalotychou
Vassiliki Kalotychou
RTRevekka Tzanetea
Revekka Tzanetea
PKPanagoula Kollia
Panagoula Kollia
ZKZoi Kontogeorgiou
Zoi Kontogeorgiou
IRIoannis Rombos
Ioannis Rombos

25 October 2021 in Journal of the Peripheral Nervous System
Verified
Journal Article
Closed access
PDF file
ZKZoi Kontogeorgiou
Zoi Kontogeorgiou
CVCharalampos Voudommatis
Charalampos Voudommatis
CKChrisoula Kartanou
Chrisoula Kartanou
DPDionysis Pandis
Dionysis Pandis
MBMarianthi Breza
Marianthi Breza
GKGEORGIA KARADIMA
GEORGIA KARADIMA

5 October 2023 in Journal of the Peripheral Nervous System
Verified
Journal Article
Open access
ZKZoi Kontogeorgiou
Zoi Kontogeorgiou
CKChrisoula Kartanou
Chrisoula Kartanou
MRMichail Rentzos
Michail Rentzos
PKPanagiotis Kokotis
Panagiotis Kokotis
EAEvangelos Anagnostou
Evangelos Anagnostou
GKGeorgia Karadima
Georgia Karadima
Background and Aims: Axonal forms of Charcot-Marie-Tooth disease (CMT) are classified as CMT2, distal hereditary motor neuropathy (dHMN) or hereditary sensory neuropathy (HSN) and can be caused by mutations in over 100 genes. We presently aimed to investigate for the first time the genetic landscape of axonal CMT in the Greek population.Methods: Sixty index patients with CMT2, dHMN or HSN were screened by a combination of Sanger sequencing (GJB1) and next-generation sequencing custom-made gene panel covering 24 commonly mutated genes in axonal CMT.Results: Overall, 20 variants classified as pathogenic or likely pathogenic were identified in heterozygous state in 20 index cases, representing 33.3% of the cohort. Of these, 14 were known pathogenic/likely pathogenic and six were designated as such according to ACMG classification, after in silico evaluation, testing for familial segregation and further literature review. The most frequently involved genes were GJB1 (11.7%), MPZ (5%) and MFN2 (5%), followed by DNM2 (3.3%) and LRSAM1 (3.3%). Single cases were identified with mutations in BSCL2, HSPB1 and GDAP1.Interpretation: A wide phenotypic variability in terms of severity and age of onset was noted. Given the limited number of genes tested, the diagnostic yield of the present panel compares favourably with studies in other European populations. Our study delineates the genetic and phenotypic variability of inherited axonal neuropathies in the Greek population and contributes to the pathogenicity characterization of further variants linked to axonal neuropathies.